AOM Infusion to Acquire PromptCare Infusion

August 31, 2026, 10:45am ET

In a reflection of ongoing M&A activity within the infusion therapy sector, AOM Infusion plans to acquire PromptCare Infusion, Healthcare Dealflow is the first to report. Neither party has issued a press announcement.

AOM Infusion is a leading provider of specialty infusion therapy that is backed by private equity firm Revelstoke Capital Partners. PromptCare Infusion is a Waud Capital Partners-backed national provider of respiratory services and home and alternate site infusion therapies.

According to a Massachusetts Health Policy Commission filing, AOM’s subsidiary, AOM PC Purchaser, LLC, will acquire all equity interests in PromptCare Infusion Buyer, Inc. from PromptCare Intermediate, LP.

The logic behind the tie-up of complementary platforms, according to the regulatory filing reviewed by Healthcare Dealflow, is to “achieve scale-based drug procurement efficiencies and also expand geographic coverage and patient access to infusion therapies.” Additionally, the deal will combine the companies’ strengths, merging AOM’s focus on IVIG products and subcutaneous injection of immunoglobulins with PromptCare’s specialty biologics and bleeding disorder programs to serve a broader range of chronic patients.

The proposed effective date for the transaction is October 16, 2026. The parties submitted an HSR filing on July 29, indicating that the deal is valued at at least $133.9 million, the 2026 HSR reporting threshold. The state filing references submissions to four other states. One of those, Oregon, determined that the transaction, filed under ARJ Infusion Services (a direct subsidiary of PromptCare), is not subject to review by the state’s oversight program.

The infusion therapy sector has been busy this year, with private equity firms showing sustained interest. Recent deals include SkyKnight Capital’s partnership with Apex Infusion Partners and Nautic Partners’ investment in KabaFusion.

Healthcare Dealflow is a healthcare M&A intelligence platform that tracks deal activity, trends and analysis across the healthcare sector for an audience of private equity firms, investment banks, corporate development teams, and transaction advisors. Subscribe to The Daily Brief here.